Mild or Moderate Covid-19

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2020 Apr 25

PMID 32329974

Citations 736

Authors

Rajesh T Gandhi

John B Lynch

Carlos Del Rio

Affiliations

Soon will be listed here.

Citing Articles

Identifying and Validating Prognostic Hyper-Inflammatory and Hypo-Inflammatory COVID-19 Clinical Phenotypes Using Machine Learning Methods.

Ji X, Guo Y, Tang L, Gao C J Inflamm Res. 2025; 18:3009-3024.

PMID: 40034687 PMC: 11874972. DOI: 10.2147/JIR.S504028.

How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months' follow-up: a national observational cohort and matched cohort study.

Ollila H, Fonseca-Rodriguez O, Caspersen I, Kalucza S, Normark J, Trogstad L BMJ Public Health. 2025; 2(1):e000336.

PMID: 40018228 PMC: 11816610. DOI: 10.1136/bmjph-2023-000336.

Understanding the potential impact of trimester-specific maternal immune activation due to SARS-CoV-2 on early human neurodevelopment and the role of cytokine balance.

Diaz-Pons A, Castano-Castano S, Ortiz-Garcia de la Foz V, Yorca-Ruiz A, Martinez-Asensi C, Munarriz-Cuezva E Brain Behav Immun Health. 2025; 44:100956.

PMID: 39990281 PMC: 11846590. DOI: 10.1016/j.bbih.2025.100956.

Metabolomic profile of severe COVID-19 and a signature predictive of progression towards severe disease status: a prospective cohort study (METCOVID).

Mallol R, Rombauts A, Abelenda-Alonso G, Gudiol C, Balsalobre M, Carratala J Sci Rep. 2025; 15(1):4963.

PMID: 39929875 PMC: 11811168. DOI: 10.1038/s41598-025-87288-x.

Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial : Author detials.

Wei J, Liu S, Bian Y, Li L, Qian B, Shen Z Sci Rep. 2025; 15(1):3875.

PMID: 39890847 PMC: 11785718. DOI: 10.1038/s41598-024-75891-3.